%0 Journal Article %J Alcoholism, clinical and experimental research %D 2012 %T Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone. %A Tetrault, Jeanette M %A Tate, Janet P %A McGinnis, Kathleen A %A Goulet, Joseph L %A Sullivan, Lynn E %A Bryant, Kendall %A Justice, Amy C %A Fiellin, David A %K Adult %K Aged %K Alanine Transaminase %K Alcoholism %K Antiretroviral Therapy, Highly Active %K Aspartate Aminotransferases %K CD4 Lymphocyte Count %K Cohort Studies %K Databases, Factual %K Drug Interactions %K Drug Toxicity %K Drug-Induced Liver Injury %K Female %K HIV Infections %K Humans %K Liver %K Liver Function Tests %K Male %K Middle Aged %K Naltrexone %K Narcotic Antagonists %K Opioid-Related Disorders %K RNA, Viral %K Veterans %N 2 %P 318-24 %R 10.1111/j.1530-0277.2011.01601.x %V 36 %X We sought to determine the impact of naltrexone on hepatic enzymes and HIV biomarkers in HIV-infected patients. %8 2012 Feb